IL0006290147
IL0006290147
TEVA PHARMA IND
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 139.96B EUR | 11.46T EUR | 10.76T EUR | 11.6T EUR |
Enterprise Value | 153.08B EUR | 11.48T EUR | 10.77T EUR | 11.62T EUR |
Valuation Multiples | ||||
Trailing P/E | 64.17x | 16,236.57x | 6,878.61x | 9,708.46x |
Forward P/E | 43.32x | -- | -- | -- |
Price to Sales | 8.08x | 662.07x | 620.14x | 867.93x |
Price to Book | 1,803.7x | 1,478.53x | 1,307.5x | 1,466.7x |
EV/Revenue | 8.84x | 662.83x | 620.9x | 868.94x |
EV/EBITDA | 35.87x | 2,718.84x | 2,181.31x | 2,940.54x |
Price to FCF (P/FCF) | 63.05x | 8,503.72x | 9,179.3x | 8,406.97x |
EV/FCF | 68.96x | 8,513.53x | 9,190.53x | 8,416.78x |
FCF Yield | 1.59% | 0.01% | 0.01% | 0.01% |